Clinical Trial Update: Dupilumab De-escalation in Pediatric Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating de-escalation strategies for dupilumab in pediatric atopic dermatitis is currently recruiting. The study is sponsored by Johns…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Atopic Dermatitis | Phase 4 | Status: RECRUITING